To provide further evidence for SMG1 as a novel PC predisposition gene, we validated our findings in an independent case-control series consisting of 532 FPC cases (defined as ≥2 first-degree relatives with PC) and 753 non-cancer controls. This evidence concerns the gene SMG1 and pachyonychia congenita.